Explainer
How blood donation works: eligibility rules and donor screening
Blood collection in the US is regulated by the FDA, which sets donor eligibility rules and product standards.[1] A donor must be in good health, pass day-of checks including temperature and hemoglobin, and can give whole blood no more than once every 8 weeks.[2][3][4] FDA's May 2023 guidance recommends that blood centres ask every donor the same individual risk-based questions about HIV risk, regardless of sex, instead of questions aimed at men who have sex with men.[5]
Donated blood is a regulated medical product. The rules on who can give, how often, and what screening happens are set by the US Food and Drug Administration and applied by blood centres.[1] This page explains those rules and the 2023 change to how donors are asked about HIV risk.
This page is general information, not medical advice. Blood centres apply the eligibility rules on the day. If you have questions about whether donating is safe for you, ask the blood centre’s staff or your clinician.
Who regulates blood
FDA’s Center for Biologics Evaluation and Research (CBER) regulates the collection of blood and blood components for transfusion and for making medicines derived from blood. It also sets standards for the products themselves.[1]
Basic eligibility and day-of checks
To give blood a donor must be in good health and free from infections that can pass through a transfusion. Staff can turn a donor away if giving blood might harm the donor or make the blood less safe.[2] On the day, staff check the donor’s temperature, blood pressure and hemoglobin.[3]
21 CFR 630.10 makes a donor ineligible if they are not in good health or if donating could harm the donor or affect the safety, purity or potency of the product.[2] The physical assessment must include oral temperature no higher than 37.5 °C (99.5 °F), blood pressure and hemoglobin or hematocrit. Allogeneic donors need at least 12.5 g/dL hemoglobin (or 38% hematocrit) if female and 13.0 g/dL if male.[3]
Whole blood can be donated no more than once every 8 weeks. Donors giving two units of red cells by apheresis must wait 16 weeks.[4]
The 2023 switch to individual risk questions
In May 2023 FDA finalised guidance recommending that blood centres drop screening questions aimed specifically at men who have sex with men and at women who have sex with them. Instead, it recommends asking every donor the same individual risk-based questions about HIV risk, regardless of sex.[5]
Under that approach, the guidance recommends that donors who report a new sexual partner, or more than one partner, in the past 3 months be asked whether they have had anal sex in that period. People who report both are deferred for 3 months from their most recent sexual contact.[6] FDA’s guidance notes that the United Kingdom in 2021 and Canada in 2022 had already adopted individual risk-based questioning, and had not reported safety concerns.[7]
The same guidance sets waiting periods for people taking HIV prevention medicines. FDA recommends a 3-month deferral after the last dose of oral PrEP or PEP, and two years after the last injection of long-acting injectable PrEP or PEP.[8] These are blood-safety rules, not advice about whether to take those medicines.
Other deferrals were shortened earlier. In April 2020 FDA cut the recommended wait after a recent tattoo or piercing, a transfusion, or contact with another person’s blood from 12 months to 3 months.[9]
Short shelf lives
Some blood products keep for only a short time. Under FDA’s dating rules, platelets stored at 20 to 24 °C expire 5 days after collection. Platelets stored at other temperatures follow the dating in the approved storage system’s instructions.[10]
- Organ and tissue donation follow different federal rules. See how organ donation works.
- For how FDA handles problems with regulated products, see the FDA recall process.
Read next
FDA recall process: Class I, II and III recalls explained
How US FDA recalls work: who starts them, what Class I, II and III mean, how the weekly Enforcement Report is published, and how to follow recalls.
Questions readers ask
Who regulates blood donation in the US?
FDA's Center for Biologics Evaluation and Research regulates the collection of blood and blood components for transfusion or for making blood-derived medicines, and sets product standards.[1]
How often can I donate whole blood?
FDA rules allow whole blood donation no more than once every 8 weeks. Double red cell donation by apheresis is limited to once every 16 weeks.[4]
What health checks happen before donating?
On the day of donation the collector checks temperature, which must not exceed 37.5 °C (99.5 °F), blood pressure and hemoglobin. FDA's minimum hemoglobin is 12.5 g/dL for female and 13.0 g/dL for male allogeneic donors.[3]
Can gay and bisexual men donate blood?
FDA's 2023 guidance recommends dropping screening questions specific to men who have sex with men and asking every donor the same questions. Under that guidance, people who report a new partner or more than one partner in the past 3 months, and anal sex in that period, are deferred for 3 months.[5][6]
Can I donate after getting a tattoo?
FDA's recommended wait after a recent tattoo or piercing was shortened from 12 months to 3 months in April 2020.[9]
How long do donated platelets last?
Under FDA's dating rules, platelets stored at 20 to 24 °C expire 5 days after collection. Platelets stored at other temperatures follow the dating in the approved storage system's instructions.[10]
Sources
· 10 claims from 3 publishers
Each numbered claim is a statement we checked against the sources listed with it. Tap a number in the text to see its sources in place.
- [1]
FDA's Center for Biologics Evaluation and Research regulates the collection of blood and blood components for transfusion or for making blood-derived medicines, and sets standards for the products. confirmedas of 2026-11-07
- Blood & Blood Products · U.S. Food and Drug Administration · Primary source (retrieved 2026-11-07)
- [2]
Under FDA regulations a blood donor must be in good health and free from transfusion-transmitted infections, and is ineligible if donating could harm the donor's health or the safety, purity or potency of the blood. confirmedas of 2026-11-01
- 21 CFR Part 630: Requirements for Blood and Blood Components Intended for Transfusion or for Further Manufacturing Use · Electronic Code of Federal Regulations (National Archives) · Primary source · 21 CFR 630.10(a) (retrieved 2026-11-07)
- [3]
On the day of donation the collector must check the donor's temperature, which must not exceed 37.5 °C (99.5 °F), blood pressure and hemoglobin or hematocrit; minimum hemoglobin is 12.5 g/dL (or a 38% hematocrit) for female and 13.0 g/dL for male allogeneic donors. confirmedas of 2026-11-01
- 21 CFR Part 630: Requirements for Blood and Blood Components Intended for Transfusion or for Further Manufacturing Use · Electronic Code of Federal Regulations (National Archives) · Primary source · 21 CFR 630.10(f)(1)-(3); (B) "Male allogeneic donors must have a hemoglobin level that is equal to or greater than 13.0 grams" (retrieved 2026-11-07)
- [4]
FDA rules limit whole blood donation to no more than once every 8 weeks, and double red cell apheresis donation to no more than once every 16 weeks. confirmedas of 2026-11-01
- 21 CFR Part 630: Requirements for Blood and Blood Components Intended for Transfusion or for Further Manufacturing Use · Electronic Code of Federal Regulations (National Archives) · Primary source · 21 CFR 630.15(a)(1)(i) (retrieved 2026-11-07)
- [5]
In May 2023 FDA finalised guidance recommending that blood establishments drop screening questions specific to men who have sex with men and instead ask every donor, regardless of sex, the same individual risk-based questions about HIV risk. confirmedas of 2023-05-12
- Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products: Guidance for Industry (May 2023) · U.S. Food and Drug Administration · Primary source · 2023-05-11 · Section III, Background (PDF; text extraction joins "risk-based" as "riskbased") (retrieved 2026-11-07)
- Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions To Reduce the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Guidance for Industry; Availability · Federal Register (U.S. Food and Drug Administration) · Primary source · 2023-05-12 · Summary (notice of availability, 12 May 2023) (retrieved 2026-11-07)
- [6]
Under the 2023 FDA guidance, donors who report a new sexual partner or more than one partner in the past 3 months are asked about anal sex in that period, and those who report both are deferred for 3 months from the most recent sexual contact. confirmedas of 2023-05-12
- Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products: Guidance for Industry (May 2023) · U.S. Food and Drug Administration · Primary source · 2023-05-11 · Section IV, Recommendations, deferral 5 (deferral 6 covers more than one partner) (retrieved 2026-11-07)
- [7]
FDA's guidance notes that the United Kingdom (2021) and Canada (2022) had already moved to individual risk-based donor questioning and had not reported safety concerns. confirmedas of 2023-05-12
- Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products: Guidance for Industry (May 2023) · U.S. Food and Drug Administration · Primary source · 2023-05-11 · Section III; also "the United Kingdom and Canada have not reported safety concerns following the implementation of this individual riskbased deferral policy" (retrieved 2026-11-07)
- [8]
FDA's guidance recommends deferring people for 3 months after the last dose of oral HIV prevention medication (PrEP or PEP) and for two years after the last injection of long-acting injectable PrEP or PEP. confirmedas of 2023-05-12
- Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products: Guidance for Industry (May 2023) · U.S. Food and Drug Administration · Primary source · 2023-05-11 · Section IV, deferrals 3 and 4; deferral 3: "Defer for 3 months from the most recent dose, an individual who has taken any medication by mouth (oral) to prevent HIV infection" (retrieved 2026-11-07)
- [9]
In April 2020 FDA shortened the recommended deferral after a recent tattoo or piercing, a transfusion or contact with another person's blood from 12 months to 3 months. confirmedas of 2023-05-12
- Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products: Guidance for Industry (May 2023) · U.S. Food and Drug Administration · Primary source · 2023-05-11 · Section III, Background (describing the April 2020 revisions) (retrieved 2026-11-07)
- [10]
Under FDA's dating rules, platelets stored at 20 to 24 °C expire 5 days after collection; platelets stored at other temperatures follow the dating in the FDA-approved or cleared storage system's instructions. confirmedas of 2026-11-01
- 21 CFR 610.53: Dating periods for licensed biological products · Electronic Code of Federal Regulations (National Archives) · Primary source · 21 CFR 610.53(c) table; next row, Platelets at "Other temperatures according to storage bag instructions": "As specified in the instructions for use by the blood collection, processing and storage system approved or cleared for such use by FDA." (retrieved 2026-11-07)
Revision history (1)
- Page created.
Created Nov 7, 2026. Last reviewed by an editor on Nov 8, 2026. Next scheduled review: May 7, 2027.
Cite this page
"How blood donation works: eligibility rules and donor screening." ContentLora, updated Nov 7, 2026. https://contentlora.com/explain/how-blood-donation-works
Spotted an error? Suggest a correction or emailcorrections@contentlora.com.